PetMed Express, Inc.
PETS
$4.08
-$0.20-4.67%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 65.32M | 71.00M | 78.24M | 62.41M | 58.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 65.32M | 71.00M | 78.24M | 62.41M | 58.87M |
| Cost of Revenue | 47.43M | 50.94M | 55.72M | 45.03M | 43.63M |
| Gross Profit | 17.88M | 20.06M | 22.53M | 17.38M | 15.24M |
| SG&A Expenses | 19.19M | 19.04M | 21.48M | 15.25M | 14.53M |
| Depreciation & Amortization | 1.77M | 1.71M | 1.68M | 994.00K | 941.00K |
| Other Operating Expenses | -- | -268.00K | -- | 344.00K | -- |
| Total Operating Expenses | 68.39M | 71.43M | 78.88M | 61.61M | 59.10M |
| Operating Income | -3.07M | -426.00K | -635.00K | 798.00K | -230.00K |
| Income Before Tax | -2.65M | 383.00K | -1.00M | 453.00K | -211.00K |
| Income Tax Expenses | -618.00K | 453.00K | -115.00K | 669.00K | 1.00K |
| Earnings from Continuing Operations | -2.03M | -70.00K | -887.00K | -216.00K | -212.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.03M | -70.00K | -887.00K | -216.00K | -212.00K |
| EBIT | -3.07M | -426.00K | -635.00K | 798.00K | -230.00K |
| EBITDA | -804.00K | 1.04M | 793.00K | 1.79M | 711.00K |
| EPS Basic | -0.10 | 0.00 | -0.04 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.08 | 0.01 | 0.02 | 0.05 | 0.01 |
| EPS Diluted | -0.10 | 0.00 | -0.04 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.08 | 0.01 | 0.02 | 0.05 | 0.01 |
| Average Basic Shares Outstanding | 20.43M | 20.38M | 20.33M | 20.33M | 20.30M |
| Average Diluted Shares Outstanding | 20.43M | 20.38M | 20.33M | 20.34M | 20.30M |
| Dividend Per Share | 0.00 | 0.30 | 0.30 | 0.30 | 0.30 |
| Payout Ratio | -0.74% | -9,002.86% | -687.94% | -2,840.28% | -2,875.47% |
